HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Autofluorescence of clofazimine in discoid lupus erythematosus.

Abstract
A 70-year-old woman developed dark reddish blue pigmentation in scarred areas of discoid lupus erythematosus after taking clofazimine intermittently over a period of 10 years. Although light microscopy of routinely processed tissue failed to define the cause of the pigment, fluorescent microscopy showed vivid red deposits concentrated around larger vessels within the dermis. These deposits were shown to correspond to birefringent red clofazimine crystals on fresh frozen sections. Although the hyperpigmentation may clinically resemble melanin, biopsy specimens from our patient revealed a loss of melanin pigment in lesional skin, suggesting a primary role for clofazimine in producing the color changes observed.
AuthorsS Kossard, E Doherty, I McColl, W Ryman
JournalJournal of the American Academy of Dermatology (J Am Acad Dermatol) Vol. 17 Issue 5 Pt 2 Pg. 867-71 (Nov 1987) ISSN: 0190-9622 [Print] United States
PMID3680675 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Clofazimine
Topics
  • Aged
  • Clofazimine (adverse effects, therapeutic use)
  • Female
  • Fluorescence
  • Humans
  • Lupus Erythematosus, Discoid (drug therapy)
  • Pigmentation Disorders (chemically induced)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: